Abnormal epicardial coronary vasomotor reactivity is associated with altered outcomes

Hélène Aélion1, Fabien Picard2, Arnaud Jégou3

  • 1Cardiology Department, Cochin Hospital, AP-HP, 75014 Paris, France; Faculty of Medicine, University of Paris Cité, 75014 Paris, France.

Insights

Abnormal epicardial coronary vasomotor reactivity (ACVR) is common in patients with ischemic symptoms and normal coronary arteries. Provocative testing (PT) safely identifies patients at high risk for adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Abnormal epicardial coronary vasomotor reactivity (ACVR) significance in patients with ischemic symptoms and non-obstructive coronary artery disease is unclear.
  • Current diagnostic strategies involve provocative testing (PT) for patients with chest pain and no significant coronary stenosis.

Purpose of the Study:

  • To evaluate the incidence, safety, and patient outcomes associated with using PT to diagnose ACVR.
  • Assess the risk of major adverse cardiovascular and cerebrovascular events (MACCE) in patients with and without ACVR.

Main Methods:

  • Retrospective observational study with a median 5-year clinical follow-up.
  • Analysis of patients undergoing coronary angiography and subsequent PT.
  • Primary outcome: incidence of ACVR. Secondary outcomes: MACCE (death, cardiovascular mortality, myocardial infarction, stroke, revascularization).

Main Results:

  • ACVR was identified in 12.4% of patients undergoing PT.
  • ACVR patients were more likely female, current smokers, and presented with suspected acute coronary syndrome.
  • Patients with ACVR had a significantly higher incidence of MACCE, including myocardial infarction and coronary revascularization.

Conclusions:

  • ACVR is a frequent finding in patients with ischemic symptoms and normal coronary arteries.
  • Provocative testing (PT) is a safe and effective strategy for identifying patients with ACVR.
  • Identifying ACVR highlights a population at increased risk for recurrent ischemic events.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
34
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
24
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65